Home LiteratureArticle Details
PMID: 467606 Published · ppublish English Journal Article

Lymphatic metastasis of tumour; persistent transport of cells.

Experientia ·Vol. 35 ·No. 6 ·1979-06-15 ·Pages 825-7

Carr J, Carr I, Dreher B, Franks CR

Abstract

A model of lymphatic metastasis established by injecting Walker rat carcinoma cells into the rat footpad was used to study the output of tumour cells from the footpad. The lymphatic efferent from the footpad was cannulated in a group of rats with advanced neoplasm; it was shown that the output of tumour cells was continuous over periods up to 90 min and ranged from 10(2)-10(5) cells/min.

MeSH Terms
Animals Carcinoma 256, Walker/pathology,physiopathology Lung Neoplasms/pathology Lymph Nodes/pathology Lymphatic Metastasis/pathology,physiopathology Male Neoplasm Transplantation Rats
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Carr J
Carr I
Dreher B
Franks C R
References (4)
4 references, click to expand
  1. The fine structure of neoplastic invasion: invasion of liver, skeletal muscle and lymphatic vessels by the Rd/3 tumour.
    J Pathol. 1976 Feb;118(2):91-9 PMID: 130474
  2. Lymphatic invasion and metastasis.
    Experientia. 1977 Jul 15;33(7):837-43 PMID: 330195
  3. Lymphatic metastasis and its inhibition: an experimental model.
    J Pathol. 1974 Jun;113(2):85-95 PMID: 4420735
  4. Lymhatic metastasis of transplantable animal neoplasms.
    Experientia. 1974 Feb 15;30(2):185-6 PMID: 4814610
Article Info
Journal
Experientia
Abbr.
Experientia
ISSN
0014-4754
Published
1979-06-15
Pages
825-7
Language
English
Region
Switzerland
NLM ID
0376547
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]